Cartesian Therapeutics eliminates CSO role, terminates Dr. Christopher Jewell effective Nov 14, 2025

Cartesian Therapeutics, Inc.

CSO position eliminated; Dr. Christopher Jewell terminated without cause effective November 14, 2025.
Separation agreement signed Oct 20, 2025 provides 12 months salary and pro-rated bonus eligibility.
Dr. Jewell releases all claims against the company in exchange for severance benefits.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.